Get started
Work

3P Clinical significance of achieving no evidence of disease in HER2-positive metastatic breast cancer: A multicenter study by Turkish Oncology Group (TOG)

Year: 2026
Type: article
Abstract: Achieving no evidence of disease (NED) in HER2-positive metastatic breast cancer (MBC) has been proposed as a surrogate for durable disease control. However, its clinical significance and predictive factors are not yet well established.
Source: ESMO Open
DOI: 10.1016/j.esmoop.2026.106106
Authors: B. Dursun, S. Yaslikaya, S. Sekmek, T. Önder, H.C. Yildirim, O. Acar, N. Sever, S. Gokcek, S. Ön, F. Aslan, G.S.Y. Keskin, Z. Sucuoglu Isleyen, G. Savas, M.E. Kalender, O. Bal, U.Y. Arslan, M. Sahbazlar, B. Cakar, H.M. Türk, H. Akbulut
Institutions: Ankara University, Cukurova University, Ankara Onkoloji Eğitim ve Araştırma Hastanesi, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Hacettepe University, Manisa Celal Bayar University, Marmara University, Dokuz Eylül University, Ege University, Ege Üniversitesi Tıp Fakültesi Hastanesi, Gülhane Eğitim ve Araştırma Hastanesi, Bezmiâlem Vakıf Üniversitesi, Bezmiâlem Vakıf Üniversitesi Hastanesi, Gazi University, Ankara Bilkent City Hospital
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,910
OpenAlex ID: W7147089657
FWCI:
Cites:
Cited by:
Related to: